Detection of quality deviations in compounded formulation: acetic acid solution, ketoconazole syrup and T4 thyroid hormone capsules

Authors

  • Fernanda Fernandes Farias Centro de Medicamentos, Instituto Adolfo Lutz (IAL), São Paulo, SP Author
  • Helena Miyoco Yano Centro de Medicamentos, Instituto Adolfo Lutz (IAL), São Paulo, SP Author
  • Eliana Della Coletta Yudice Centro de Laboratório Regional - Santo André, Instituto Adolfo Lutz (IAL), São Paulo, SP Author
  • Marcos Paulo Guilherme Centro de Medicamentos, Instituto Adolfo Lutz (IAL), São Paulo, SP Author
  • Valéria Adriana Pereira Martins Centro de Medicamentos, Instituto Adolfo Lutz (IAL), São Paulo, SP Author
  • Luz Marina Trujillo Centro de Medicamentos, Instituto Adolfo Lutz (IAL), São Paulo, SP Author
  • Maria Cristina Santa Bárbara Centro de Medicamentos, Instituto Adolfo Lutz (IAL), São Paulo, SP Author
  • Blanca Elena Ortega Markman Centro de Medicamentos, Instituto Adolfo Lutz (IAL), São Paulo, SP Author

DOI:

https://doi.org/10.22239/2317-269X.01134

Keywords:

Compounding Formulations, Health Surveillance, Pharmaceutical Assistance, Public Health

Abstract

Introduction: Incorrect doses of the active ingredient in compounding formulations make up common errors in the manipulation, which can cause harm to the patient’s health, reflecting the possible absence of Good Handling Practices (GHP). Objective: To report quality deviations in the medicines acetic acid solution, ketoconazole syrup and T4 capsules. Method: Identification by chemical reactions and by HPLC, content by titration and HPLC, pH by potentiometry. Results: Positive identification for acetic acid with 98.20% content compatible with glacial acetic acid, in disagreement with the prescription of 5% solution. The ketoconazole content of 16.20 mg/mL found in the syrup corresponds to 81.00% of the declared, the minimum specification is 90.00%; pH 8.0; positive identification for anionic surfactant component in the syrup. The results found were: 25 μg T4 capsules were 177.70 μg and for the 200 μg capsules it was 174.44 μg, corresponding to 710.96% and 87.22% of the declared content, respectively, in disagreement with specification 90.00% and 110.00%. Conclusions: The study illustrated the detection of quality deviations in manipulated drugs from different pharmacies, due to pharmacotechnical misconceptions, lack of quality control and lack of GHP implementation. Frequent inspection prevents health risks to the population.

Downloads

Download data is not yet available.

Author Biographies

  • Fernanda Fernandes Farias, Centro de Medicamentos, Instituto Adolfo Lutz (IAL), São Paulo, SP
    Pesquisadora científica do Núcleo de Ensaios Físicos e Químicos em Medicamentos do Centro de Medicamentos, Cosméticos e Saneantes.
  • Helena Miyoco Yano, Centro de Medicamentos, Instituto Adolfo Lutz (IAL), São Paulo, SP
    Pesquisadora científica do Núcleo de Ensaios Físicos e Químicos em Medicamentos do Centro de Medicamentos, Cosméticos e Saneantes.
  • Eliana Della Coletta Yudice, Centro de Laboratório Regional - Santo André, Instituto Adolfo Lutz (IAL), São Paulo, SP
    Pesquisadora científica do Núcleo de Ciências Químicas e Bromatológicas do Centro de Laboratório Regional de Santo André
  • Marcos Paulo Guilherme, Centro de Medicamentos, Instituto Adolfo Lutz (IAL), São Paulo, SP
    Agente Técnico de Assistência à Saúde- Farmacêutico do Núcleo de Ensaios Físicos e Químicos em Medicamentos do Centro de Medicamentos, Cosméticos e Saneantes.
  • Valéria Adriana Pereira Martins, Centro de Medicamentos, Instituto Adolfo Lutz (IAL), São Paulo, SP
    Pesquisadora científica do Núcleo de Ensaios Físicos e Químicos em Medicamentos do Centro de Medicamentos, Cosméticos e Saneantes.
  • Luz Marina Trujillo, Centro de Medicamentos, Instituto Adolfo Lutz (IAL), São Paulo, SP
    Pesquisadora científica do Núcleo de Ensaios Físicos e Químicos em Medicamentos do Centro de Medicamentos, Cosméticos e Saneantes.
  • Maria Cristina Santa Bárbara, Centro de Medicamentos, Instituto Adolfo Lutz (IAL), São Paulo, SP
    Pesquisadora científica do Núcleo de Ensaios Físicos e Químicos em Cosméticos e Saneantes do Centro de Medicamentos, Cosméticos e Saneantes.
  • Blanca Elena Ortega Markman, Centro de Medicamentos, Instituto Adolfo Lutz (IAL), São Paulo, SP
    Pesquisadora científica VI do Núcleo de Ensaios Físicos e Químicos em Medicamentos do Centro de Medicamentos, Cosméticos e Saneantes.

Published

2018-08-31

Issue

Section

Articles

How to Cite

Detection of quality deviations in compounded formulation: acetic acid solution, ketoconazole syrup and T4 thyroid hormone capsules. (2018). Health Surveillance under Debate: Society, Science & Technology , 6(3), 22-27. https://doi.org/10.22239/2317-269X.01134

Most read articles by the same author(s)